Main Street Financial Solutions »

Adaptimmune Therapeutics shares owned by Main Street Financial Solutions

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Main Street Financial Solutions from 13F filings

Historical chart of Main Street Financial Solutions investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Main Street Financial Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Main Street Financial Solutions

Quarter filed Position value Share count Share price at filing
2024-03-31 $49k 31k 1.58
2023-12-31 $25k 31k 0.79
2023-09-30 $24k 31k 0.78

More positions owned by Main Street Financial Solutions

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core Us Aggbd Et (AGG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Specialized Funds Div App Etf (VIG)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)

View all positions for Main Street Financial Solutions

Top funds holding Adaptimmune Therapeutics

NEA Management Company
Baillie Gifford & Co
Long Focus Capital Management
Baker Bros. Advisors
Partner Fund Management
Bank of America Corporation
Tang Capital Management
Citadel Advisors
Syncona Portfolio
Jpmorgan Chase & Co
Redmile Group
GSA Capital Partners
Acuitas Investments
Millennium Management
DAFNA Capital Management

View all funds holding Adaptimmune Therapeutics